MATERIALS AND METHODS Patienf population, image selection, and grading of heart
intensity. We examined the 1-131 MIBG posterior abdominal images from 168 patients (86 …

The report in this issue of the Journal by Nakajo and co-workers of an inverse relationship
be tween the accumulation of [13ll] metaiodobenzylguanidine (1-131 MIBG) in the heart and …

The radiopharmaceutical iodine 131 metaiodobenzylguanidine (I-131 MIBG) has been
shown to locate pheochromocytomas scintigraphically with a false-negative rate of …

Studies at the University of Michigan have shown that 131 I-metaiodobenzylguanidine (131 I-
MIBG) is an effective agent for the diagnosis and localization of pheochromocytomas and …

Recently 131I-MIBG (metaiodobenzylguanidine), an adrenergic tissue-localizing
radiopharmaceutical, has been used for diagnosis of pheochromocytoma. In a retrospective …

[en] The safety and efficacy of 131-I meta-iodobenzylguanidine (131-I-MIBG) has been
demonstrated in a series of 118 patients. No false positive and only one proven false …

We used a new radiopharmaceutical agent,[131I] meta-iodobenzylguanidine ([131I] MIBG),
to produce scintigraphic images of pheochromocytomas in eight patients. One day or more …

With few exceptions, the hope that radiopharmaceuticals could be developed to deliver local
ra diation to sites of cancer has not been realized. In some areas, we have achieved …

Ninety-nine patients suspected of having pheochromocytoma were studied with [131I]
metaiodobenzylguanidine scintigraphy, and 92 of them were studied with computed …

ScinTIGraphy with 131I‐MIBG has located most pheochromocytomas. The detected tumors
have been intra‐adrenal, extra‐adrenal, malignant, and familial in type. The method is safe …